Brief: NovaBay Says Hypochlorous Acid Solution Got U.S. EPA Approval For SARS-CoV-2 Kill Claim
Dec 14 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS - HYPOCHLOROUS ACID SOLUTION HAS
RECEIVED U.S. ENVIRONMENTAL PROTECTION AGENCY APPROVAL FOR KILL
CLAIM AGAINST SARS-COV-2
Source text for Eikon: ID:nBw24kstxa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing